Xianzheng Zhou

Ministry of Education of the People's Republic of China — China

Immunology and Microbiology · Life Sciences

28h-index3.6kcitations69works3.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(28), CAR-T cell therapy research(24), Virus-based gene therapy research(16), Immunotherapy and Immune Responses(14), RNA Interference and Gene Delivery(11)

Publications69 total

A hybrid vibration suppression method based on PID control and input shaping in minimally invasive surgical robots
Measurement·2025
Vibration response-based collision detection method for robot-assisted minimally invasive plate implantation surgery
Measurement·2025· 1 citedOpen Access
Particle swarm optimization-based unscented Kalman Filter for tremor suppression in minimally invasive surgical robots
Biomedical Signal Processing and Control·2025· 2 cited
Computer-aided robotics for applications in fracture reduction surgery: Advances, challenges, and opportunities
iScience·2024· 15 citedOpen Access
A Dual‐Mode Robot‐Assisted Plate Implantation Method for Femoral Shaft Fracture
International Journal of Medical Robotics and Computer Assisted Surgery·2024· 1 citedOpen Access
Forecasting the equity premium: Do deep neural network models work?
Modern Finance·2023· 35 citedOpen Access
Supplemental Table 1 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023Open Access
Data from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023Open Access
Supplementary Figure 1 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023Open Access
Supplemental Table 2 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023Open Access
Supplemental Figure Legends from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023Open Access
Supplemental Figure Legends from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023Open Access
Supplementary Figure 1 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023· 1 citedOpen Access
Supplementary Figure 2 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023Open Access
Supplemental Table 1 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023Open Access
Supplementary Figure 2 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023Open Access
Data from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023Open Access
Supplemental Table 2 from IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <i>In Vivo</i> Expansion, and Enhanced Function
2023Open Access
Preclinical Development of Non-Edited CD7 CAR-Modified Invariant NKT Cell Therapy for T-Cell Malignancies and Acute Myeloid Leukemia
Blood·2022· 2 cited
Exploring the Possibility to Feminize Four Macro-level International Relations Theories
Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research·2022Open Access
page 1 of 4Next →

Frequent Co-authors

Xin Huang(10), Bruce R. Blazar(9), Mikael Jondal(8), Xin Huang(8), Jakub Tolar(7), R. Scott McIvor(6), Changming Lu(5), Mitchell S. Cairo(5), Bruce L. Levine(5), Carl H. June(5), Andrew Wilber(5), Drew M. Pardoll(4), Hongfeng Guo(4), Syam Tammana(4), Ussama M. Abdel Motal(4), Yanchao Guo(4), Jianping Bi(4), Ron McElmurry(3), Joerg Uwe Schmohl(3), Bin Zhang(3)